![Clinical utility of tumour marker velocity of cancer antigen 15–3 (CA 15–3) and carcinoembryonic antigen (CEA) in breast cancer surveillance - ScienceDirect Clinical utility of tumour marker velocity of cancer antigen 15–3 (CA 15–3) and carcinoembryonic antigen (CEA) in breast cancer surveillance - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0960977620301120-fx1.jpg)
Clinical utility of tumour marker velocity of cancer antigen 15–3 (CA 15–3) and carcinoembryonic antigen (CEA) in breast cancer surveillance - ScienceDirect
Elevated Levels of Serum Tumor Markers CEA and CA15-3 Are Prognostic Parameters for Different Molecular Subtypes of Breast Cancer | PLOS ONE
![OWise on Twitter: "🔍Do you know what the blood markers CA 15-3, CA 27-29 and CEA are? Blood tests🩸measure the levels of these proteins in breast cancer patients. Read below to find OWise on Twitter: "🔍Do you know what the blood markers CA 15-3, CA 27-29 and CEA are? Blood tests🩸measure the levels of these proteins in breast cancer patients. Read below to find](https://pbs.twimg.com/media/E2OlO4SXEAIVjza.jpg:large)
OWise on Twitter: "🔍Do you know what the blood markers CA 15-3, CA 27-29 and CEA are? Blood tests🩸measure the levels of these proteins in breast cancer patients. Read below to find
![The prognostic significance of preoperative tumor marker (CEA, CA15-3) elevation in breast cancer patients: data from the Korean Breast Cancer Society Registry | SpringerLink The prognostic significance of preoperative tumor marker (CEA, CA15-3) elevation in breast cancer patients: data from the Korean Breast Cancer Society Registry | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs10549-019-05357-y/MediaObjects/10549_2019_5357_Fig2_HTML.png)
The prognostic significance of preoperative tumor marker (CEA, CA15-3) elevation in breast cancer patients: data from the Korean Breast Cancer Society Registry | SpringerLink
![CEA, CA 15-3, and TPS as Prognostic Factors in the Follow-up Monitoring of Patients After Radical Surgery for Breast Cancer | Anticancer Research CEA, CA 15-3, and TPS as Prognostic Factors in the Follow-up Monitoring of Patients After Radical Surgery for Breast Cancer | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/38/1/465/F1.large.jpg)
CEA, CA 15-3, and TPS as Prognostic Factors in the Follow-up Monitoring of Patients After Radical Surgery for Breast Cancer | Anticancer Research
![Elevation of serum CEA and CA15‑3 levels during antitumor therapy predicts poor therapeutic response in advanced breast cancer patients Elevation of serum CEA and CA15‑3 levels during antitumor therapy predicts poor therapeutic response in advanced breast cancer patients](https://www.spandidos-publications.com/article_images/ol/14/6/ol-14-06-7549-g01.jpg)
Elevation of serum CEA and CA15‑3 levels during antitumor therapy predicts poor therapeutic response in advanced breast cancer patients
Elevated Levels of Serum Tumor Markers CEA and CA15-3 Are Prognostic Parameters for Different Molecular Subtypes of Breast Cancer | PLOS ONE
![Limited usefulness of serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels for gastrointestinal and whole-body cancer screening | Scientific Reports Limited usefulness of serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels for gastrointestinal and whole-body cancer screening | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-020-75319-8/MediaObjects/41598_2020_75319_Fig1_HTML.png)
Limited usefulness of serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels for gastrointestinal and whole-body cancer screening | Scientific Reports
![Elevation of serum CEA and CA15‑3 levels during antitumor therapy predicts poor therapeutic response in advanced breast cancer patients Elevation of serum CEA and CA15‑3 levels during antitumor therapy predicts poor therapeutic response in advanced breast cancer patients](https://www.spandidos-publications.com/article_images/ol/14/6/ol-14-06-7549-g00.jpg)
Elevation of serum CEA and CA15‑3 levels during antitumor therapy predicts poor therapeutic response in advanced breast cancer patients
![Tumor Markers of Breast Cancer: Role in Early Diagnosis, Monitoring Response to Therapy and Determination of Prognosis Tumor Markers of Breast Cancer: Role in Early Diagnosis, Monitoring Response to Therapy and Determination of Prognosis](http://pubs.sciepub.com/jcrt/4/5/2/image/tab1.png)
Tumor Markers of Breast Cancer: Role in Early Diagnosis, Monitoring Response to Therapy and Determination of Prognosis
![CEA, CA19-9, circulating DNA and circulating tumour cell kinetics in patients treated for metastatic colorectal cancer (mCRC) | British Journal of Cancer CEA, CA19-9, circulating DNA and circulating tumour cell kinetics in patients treated for metastatic colorectal cancer (mCRC) | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41416-021-01431-9/MediaObjects/41416_2021_1431_Fig1_HTML.png)
CEA, CA19-9, circulating DNA and circulating tumour cell kinetics in patients treated for metastatic colorectal cancer (mCRC) | British Journal of Cancer
![PDF] Tumor Markers of Breast Cancer: Role in Early Diagnosis, Monitoring Response to Therapy and Determination of Prognosis | Semantic Scholar PDF] Tumor Markers of Breast Cancer: Role in Early Diagnosis, Monitoring Response to Therapy and Determination of Prognosis | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/54ce5e0004d854229da124b4ed00755e2e2df55b/6-Table1-1.png)